Jones Financial Companies
TELA icon

Jones Financial Companies’s TELA Bio TELA Stock Holding History

Jones Financial Companies’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,888
Closed -$4.96K – 3504
2024
Q3 		$4.96K Buy
+1,888
New +$6.71K ﹤0.01% 2446

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Jones Financial Companies's TELA Position: Q4 2024 in Review

Jones Financial Companies sold out of TELA Bio (TELA) in Q4 2024, closing a stake of 1,888 shares — an estimated $4.96K sold.

Jones Financial Companies first reported a position in TELA in Q3 2024 and held it in 1 quarter. The position peaked at $4.96K in Q3 2024. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2024.

  • Jones Financial Companies reported no remaining TELA Bio position as of Q4 2024 after selling out during the quarter.
  • Jones Financial Companies sold 1,888 TELA Bio shares in Q4 2024, an estimated $4.96K.
  • Jones Financial Companies first reported a position in TELA Bio in Q3 2024 and held it in 1 quarter.
  • Jones Financial Companies's TELA Bio position peaked at $4.96K in Q3 2024.
  • 47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2024.

Based on Jones Financial Companies's 13F filing for Q4 2024, filed 6 Feb 2025.